-
Diabetes Res. Clin. Pract. · Feb 2013
Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
- Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Kanako Mori, Hisato Tatsuoka, Atsuko Matsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, and Hiroyuki Koshiyama.
- Center for Diabetes and Endocrinology, Tazuke Kofukai Foundation Medical Research Institute Kitano Hospital, Osaka, Japan.
- Diabetes Res. Clin. Pract. 2013 Feb 1;99(2):e21-3.
AbstractWe retrospectively examined the frequency of bladder cancer in Japanese patients with type 2 diabetes in relation to use of pioglitazone. Among a total of 663 patients identified to be taking pioglitazone, 9 had bladder cancer (1.36%). Overall the hazard ratio of 1.75 [95% CI: 0.89-3.45] for pioglitazone for bladder cancer was not significant. However the prevalence of bladder cancer was 2.10% in patients taking pioglitazone for less than 24 months which was significant increased (HR 2.73 [95% CI: 1.11-6.72]).Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.